Cargando…

Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach

Metabolic Associated Fatty Liver Disease (MASLD) is a condition that is often present in patients with a history of cholecystectomy. This is because both situations share interconnected metabolic pathways. This study aimed to establish a predictive model that allows for the identification of patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suárez, Miguel, Martínez, Raquel, Torres, Ana María, Ramón, Antonio, Blasco, Pilar, Mateo, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607671/ https://www.ncbi.nlm.nih.gov/pubmed/37892625 http://dx.doi.org/10.3390/jcm12206489

Ejemplares similares

A Machine Learning-Based Method for Detecting Liver Fibrosis
por: Suárez, Miguel, et al.
Publicado: (2023)

Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients
por: Šeda, Ondrej, et al.
Publicado: (2019)

The impact of cortisol in steatotic and non‐steatotic liver surgery
por: Cornide‐Petronio, María Eugenia, et al.
Publicado: (2017)

Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic Livers
por: Haq, Adeel, et al.
Publicado: (2023)

Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion
por: Jiménez-Castro, Mónica B., et al.
Publicado: (2019)

Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts
por: Da, Ben L, et al.
Publicado: (2022)

The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers
por: Chen, Hao, et al.
Publicado: (2022)

Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
por: Takahashi, Yoshihisa, et al.
Publicado: (2023)

Role of Dietary Nutritional Treatment on Hepatic and Intestinal Damage in Transplantation with Steatotic and Non-Steatotic Liver Grafts from Brain Dead Donors
por: Micó-Carnero, Marc, et al.
Publicado: (2021)

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
por: Staufer, Katharina, et al.
Publicado: (2023)

The Role of Neuregulin-1 in Steatotic and Non-Steatotic Liver Transplantation from Brain-Dead Donors
por: Micó-Carnero, Marc, et al.
Publicado: (2022)

Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population
por: Dalbeni, Andrea, et al.
Publicado: (2023)

The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors
por: Avalos-de León, Cindy G., et al.
Publicado: (2019)

FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
por: Arvaniti, Pinelopi, et al.
Publicado: (2023)

Central Portalization Correlates with Fibrosis but Not with Risk Factors for Nonalcoholic Steatohepatitis in Steatotic Chronic Hepatitis C
por: Lee, Hwajeong, et al.
Publicado: (2014)

Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor
por: Yang, Dong-Jing, et al.
Publicado: (2021)

How to Preserve Steatotic Liver Grafts for Transplantation
por: Patrono, Damiano, et al.
Publicado: (2023)

Tumor necrosis factor‐α‐mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice
por: Osawa, Yosuke, et al.
Publicado: (2018)

Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion
por: Mosbah, I Ben, et al.
Publicado: (2010)

The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death
por: Avalos-de León, Cindy G., et al.
Publicado: (2019)

Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver
por: Guillén, Natalia, et al.
Publicado: (2009)

More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
por: Lasch, Alexandra, et al.
Publicado: (2021)

Ghrelin Restores the Disruption of the Circadian Clock in Steatotic Liver
por: Wang, Qin, et al.
Publicado: (2018)

Waiting for the changes after the adoption of steatotic liver disease
por: Yoon, Eileen L., et al.
Publicado: (2023)

Changes in m6A in Steatotic Liver Disease
por: Petri, Belinda J., et al.
Publicado: (2023)

Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver
por: Dijkstra, Hildebrand, et al.
Publicado: (2014)

The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
por: Paklar, Natasa, et al.
Publicado: (2023)

Application of Machine Learning in Hospitalized Patients with Severe COVID-19 Treated with Tocilizumab
por: Ramón, Antonio, et al.
Publicado: (2022)

Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies
por: Raigani, Siavash, et al.
Publicado: (2020)

Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
por: Platek, Anna E., et al.
Publicado: (2023)

Allopurinol versus Febuxostat: A New Approach for the Management of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
por: Al-Shargi, Amani, et al.
Publicado: (2023)

The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
por: Vesković, Milena, et al.
Publicado: (2023)

Hepatocyte apoptosis is enhanced after ischemia/reperfusion in the steatotic liver
por: Suzuki, Takeshi, et al.
Publicado: (2011)

Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice
por: Li, Shaowei, et al.
Publicado: (2017)

Niacin‐Induced Anicteric Microvesicular Steatotic Acute Liver Failure
por: Leung, Kenneth, et al.
Publicado: (2018)

Multiparametric ultrasound imaging for the assessment of normal versus steatotic livers
por: Basavarajappa, Lokesh, et al.
Publicado: (2021)

Double-lobectomy in a steatotic liver transplantation rat model
por: Fan, Lin, et al.
Publicado: (2021)

Integrating social nutrition principles into the treatment of steatotic liver disease
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2023)

Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease
por: Semmler, Georg, et al.
Publicado: (2023)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
por: Chan, Wah-Kheong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_re8ichi8k26ejo5n7vt7vmljk3